SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-20-010592
Filing Date
2020-05-13
Accepted
2020-05-13 16:30:50
Documents
1
Period of Report
2020-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 3885
  Complete submission text file 0001437749-20-010592.txt   5235
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 POWELL STREET SUITE 1150 EMERYVILLE CA 94608
Business Address
Jones Andrew D. (Reporting) CIK: 0001811872 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33678 | Film No.: 20873597